Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Alex PearsonPaula ProszekJavier PascualCharlotte FribbensMonee K ShamsherBelinda KingstonBen O'LearyMaria T Herrera-AbreuRosalind J CuttsIsaac Garcia-MurillasHannah ByeBrian A WalkerDavid Gonzalez De CastroLina YuanSabri JamalMichael HubankElena Lopez-KnowlesEugene F SchusterMitch DowsettPeter OsinAshutosh NerurkarMarina PartonAlicia F C OkinesStephen R D JohnstonAlistair RingNicholas C TurnerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
Our research identifies multiple therapeutic opportunities for advanced breast cancer and identifies the previously underappreciated acquisition of NF1 mutations.